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LABORATORY INVESTIGATION
Aluminum inhibits hemoglobin synthesis but enhances iron
uptake in Friend erythroleukemia cells
KENNETH ABREO, JONATHAN GLASS, and M'Liss SELLA
Department of Medicine, Sections of Nephrology and Hematology, Louisiana State University Medical Center, Shreveport, Louisiana, USA
Aluminum inhibits hemoglobin synthesis but enhances iron uptake in
Friend erythroleukemia cells. Aluminum (Al) overload in dialysis pa-
tients and experimental animals is associated with the development of
anemia. However, the precise mechanisms of erythrocyte Al uptake
and toxicity are poorly understood. Al accumulation, hemoglobin (Hb)
synthesis and cell growth were evaluated in dimethysulfoxide (DMSO)-
induced Friend erythroleukemia cells (FEC), a model system for
erythroid differentiation. FEC were grown in media containing either Al
citrate, transferrin-aluminum (Tf-Al), Tf or no additions. Al accumula-
tion occurring only in cells grown in Tf-Al containing media was
detected at 24 hours and increased linearly up to 96 hours after
induction. By 96 hours, 200 36 g Al/liter lysed cells were detected in
Tf-A1 grown cells versus 5 1 ig Al/liter lysed cells in cells grown in
Al citrate (P < 0.001). Tf-Al inhibited Hb synthesis at 72 hours after
induction. At 96 hours 50 15% cells were benzidine positive when
grown in Tf-Al compared to 76 15% in Al citrate (P < 0.001). FEC
grown in increasing concentrations of Tf-Al (100 to 500 sg/ml) showed
inhibition of Hb synthesis at lower concentrations of Tf-Al at 100 g/ml
than for cell growth at 300 g/ml. Higher concentrations of Tf-Al (>300
g/ml) did not further inhibit Hb synthesis or cell growth. Iron (Fe) and
Tf uptake were increased in Al loaded FEC compared to control cells.
The increased Tf uptake was probably the result of increased Tf
receptor expression on FEC since Tf cell cycling time was unchanged.
These data indicate that Al utilizes the Tf uptake pathway for entry into
erythrocyte precursors. Al is toxic at sites distal to Fe uptake, possibly
at the heme and/or globin synthetic pathways, resulting in decreased Hb
synthesis and cell growth.
Al overload in dialysis patients is associated with the devel-
opment of encephalopathy [1], and osteomalacia [2] and a
microcytic anemia [3—13]. Following the initial report by Elliot
and Macdougall [3], a number of studies have reported the
occurrence of Al induced anemia in dialysis patients [4—13].
Removal of Al from dialysate and/or treatment with the chelator
deferoxamine has resulted in the reversal of this anemia [6,
9—13], pointing to Al as the etiologic agent in this process. We
have also shown that an increase in erythrocyte Al levels
occurred with this anemia and chelation with deferoxamine
and/or removal of diaysate Al resulted in decreased erythrocyte
Al content and amelioration of anemia in hemodialysis patients
[12, 13].
More direct evidence for Al as an etiologic agent in anemia
comes from animal studies in which anemia has been shown to
develop in Al loaded normal and uremic animals [9, 14—16].
Although it is clear that Al causes anemia in man and animals,
the precise mechanisms of Al uptake and toxicity in erythro-
cytes are poorly understood. Except for the report by Miaden-
ovic [17] in which Al and Tf inhibited human erythroid colony
(CFU-E) growth, to our knowledge no other investigations into
Al uptake, transport and toxicity in erythrocytes have been
reported. Since Al like Fe binds to Tf [18—20], it could utilize the
Tf-binding Fe-uptake route for entry into erythrocytes. Al in
erythroid precursor cells could interfere with cellular Fe uptake
and transport and/or disrupt heme and/or globin synthesis. The
well established Friend erythroleukemia cell (FEC) line [21,
22], which can be induced by dimethylsulfoxide (DMSO) to
undergo a coordinated program of Fe uptake and Hb synthesis
resembling the final stages of erythroid differentiation, serves as
a model system to test the proposed mechanisms of erythrocyte
Al uptake and toxicity. Present studies describe Al uptake and
its effect on cell growth, Hb synthesis and Fe uptake in DMSO
induced FEC in culture.
Methods
FEC cultures
FEC were grown in RPMI 1640 media containing 10% fetal
calf serum and 160 p.g/ml penicillin (regular media) in a humid-
ified incubator containing 5% CO2 in air. FEC were subcultured
to yield a clone in which 80 to 90% cells demonstrated Hb
production after four days of exposure to 1.5% DMSO (Sigma
Chemical Co., St. Louis, Missouri, USA).
Preparation of Tf-A1 and Tf-Fe
Purified human Tf (98% pure, Sigma Chemical Co.) was
saturated with Al as described by Trapp [18]. Al citrate (Pfaltz
and Bauer, Waterbury, Connecticut, USA) was added to Tf in
a ratio of 2 mol of elemental Al per mol Tf, in the presence of
0.04 M NaHCO3. Tf saturation with Al was determined by
absorbance at 242 and 290 nm [18]. Purified human Tf was
saturated with 59Fe, and labeled with 125!as described by Glass
et al [23]. Tf saturation with Fe was measured by absorbance at
470 nm.
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Hemoglobin synthesis and cell growth in Al-loaded FEC
FEC were plated at 1 x l0 cells/mi in regular media to which
1.5% DMSO alone was added or to which 1.5% DMSO and one
of the following were added: Tf (500 .tg/ml), Al citrate (340
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Fig. 1. Al uptake by DMSO-induced FEC grown in regular media C,
(U), media containing Al citrate (0), Tf(A) and Tf-Al (•) at24, 48, 72
and 96 hours after induction. Results represent means SE of 6
experiments, *P < 0.001, Tf-Al versus C, Tf, Al.
g/1iter elemental Al) or Tf-Al (500 jsg Tffml containing 340
pg!iiter elemental Al). Aliquots of cells grown in the different
media were harvested at 24, 48, 72 and 96 hours following initial
plating and assessed for Al content as described by us previ-
ously [121; Hb production was measured by percent benzidine
stained cells as described by Orkin, Harosi and Leder [24] and
cell growth.
In other experiments, FEC were plated at 1 X i05 cells/mi in
regular media to which 1.5% DMSO and varying concentrations
of Tf-Al (100 to 500 tg/ml) were added. At 96 hours after
induction, Hb production was assessed by percent benzidine
stained cells, Hb concentration (g/l06 cells) was determined as
described by Tsiftsoglou et al [251 and cell growth was deter-
mined.
Fe and Tf uptake in Al-loaded FEC
FEC were grown in regular media with 1.5% DMSO (control)
or with 1.5% DMSO and 500 j.g/mi Tf-Al (experimental).
Aliquots of cells were harvested from control and experimental
media at 24, 48, 72 and 96 hours. Cells were incubated at 1 x i0
cells/mi in PBG containing I 59Fe, '251-Tf for 30 minutes in
a water bath at 37°C. At five minute intervals 100 tl aliquots of
cells were removed and the reaction stopped by diluting with
0,5 ml ice-cold PBG. Cells were washed two times with PBG
and cellular radioactivity counted in a gamma counter. The
uptake of 59Fe and '251-Tf was expressed in molecules/cell/
minute and Tf cell-cycle time calculated as described [261.
Statistical methods
The results of Al uptake by FEC and Al induced inhibition of
Hb synthesis and cell growth were compared using the Dun-
can's multiple range post hoc test. The results of Fe and Tf Al-Tf.
uptake in Al loaded FEC were compared using a two-way
analysis of variance with paired comparison with time and Al as
independent variables, followed by post hoc tests.
Results
DMSO-induced FEC take up Al from Tf-Al
As shown in Figure 1 DMSO-induced FEC grown in media
containing Tf-Al showed an increased uptake of Al at 24 hours.
Al uptake increased in a linear fashion at 48, 72 and 96 hours
after induction with concentrations of 200 36 pg/liter lysed
cells at 96 hours. Cells grown in regular media or media
containing Al citrate or with Tf without Al showed no Al
uptake. To determine if Al accumulation was unique to FEC, Al
uptake was measured in rabbit reticulocytes incubated for 30
minutes either with phosphate buffered glucose (PBG), PBG
and Al citrate or PBG and Al-Tf. Al content of reticulocytes
was 43.8 13 pg/liter (N = 19) in the absence of Al, 62.5 13
pg/liter (N = 9) in Al citrate and 313 81 pg/liter (N = 6) in
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Fig. 2. DMSO-induced FEC Hb synthesis as assessed by % benzidine
positive cells and cell growth in regular media C (0) and media
containing Tf-Al (•) at24, 48, 72 and 96 hours after induction. Results
represent means 5E of 6 experiments, *D < 0.001, Tf-A1 versus C.
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Fig. 3. Hemog!obin synthesis assessed by Hb
30 concentration (S) and % benzidine positive
cells (0), and cell growth (A) in DMSO-
induced FEC grown in varying concentrations
20 (100 to 500 g/ml) of Tf-A! at 96 hours after
induction. Results represent means SE of 6
experiments, *D < 0.001. The first significant
10 decrease is denoted by *< 0.001. In the
measurement of benzidine positive cells, a
further significant decrease was observed and
is also noted by an .
Tf-Al inhibits DMSO-induced FEC Hb synthesis
As shown in Figure 2, Hb production as assessed by the
percentage of benzidine positive cells did not increase until 72
hours after induction in cells grown in regular media, at which
time Hb production was significantly decreased in cells grown
in Tf-Al containing media (P < 0.001). At 96 hours following
induction, the percentage of benzidine positive cells in the Tf-Al
group still lagged behind the regular media. There was no
difference in the percentage of benzidine positive cells between
cells grown in regular media and those grown in Al citrate or Tf
containing media.
Tf-Al inhibits DMSO-induced FEC growth
As shown in Figure 2 DMSO-induced FEC exhibited a small
but significant decrease of cell growth in media containing Tf-Al
compared to cells grown in regular media at 96 hours after
induction. The slight effect on cell proliferation appears to lag
behind the effect on Hb production. No differences in cell
number were seen when cells grown in regular media were
compared with those grown in media containing Al or Tf at
similar time intervals.
Hb production and cell growth in FEC grown in varying
concentrations of Tf-Al
As shown in Figure 3 Hb synthesis as assessed by the
percentage of benzidine positive cells and measured Hb con-
centration was inhibited at a lower concentration of 100 ig/ml
of Tf-Al. Cell growth inhibition was not seen until a threefold
higher concentration of Tf-Al or 300 ig/ml of Tf-Al was present.
Higher concentrations of Tf-Al did not cause further reductions
in Hb concentrations or cell growth.
Fe and Tf uptake in Al-loaded FEC
To determine if decreased Hb production was the result of
decreased If and/or Fe uptake the rate of '251-Tf and 59Fe
uptake was measured at various times after DMSO induction in
cells grown in the presence or absence of Tf-Al. As shown in
Figure 4 significantly increased uptake of Fe and Tf occurred
when assessed at 24, 48, 72 and 96 hours in DMSO-induced
FEC grown in Al-Tf containing media compared to control
media. Calculated Tf cell cycling time was similar for Al-loaded
FEC and control FEC at 5.0 0.2 minutes. These data suggest
that Tf receptors were operating normally and that If-Al caused
increased expression of Tf receptors.
Discussion
A major fraction of Al in serum is bound to protein, primarily
Tf [18—20]. Citrate has been suggested as the most probable
small molecular binder for the non-protein bound fraction of
serum Al [271. Therefore, Al uptake was evaluated in FEC
grown in control media and in media containing If-Al, Tf and Al
citrate. Aluminum was taken up by FEC grown in media
containing Tf-Al and not Al citrate. A linear increase in cellular
Al concentration occurred in FEC grown in media containing
Tf-Al. Similar uptake of Al was obtained in rabbit reticulocytes
exposed for 30 minutes to Tf-Al with no uptake from Al citrate,
providing further evidence that cells acquire Al via Tf mediated
endocytosis.
Aluminum accumulation in FEC resulted in inhibition of Hb
synthesis and cell growth (Figs. 2 and 3). Comparison of the
time-response curves obtained for FEC grown in Tf-Al and for
FEC grown in media with no added Al showed decreased Hb
accumulation in Al-loaded FEC at 48 and 72 hours (Fig. 2)
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followed by decreased cell growth at 96 hours (Fig. 2). The
dose-response curves (Fig. 3) obtained by growing FEC in
increasing concentrations of Tf-Al showed a sharp decrease in
Hb accumulation at concentrations of Tf-Al (100 g/ml) in
media which were threefold lower than Tf-Al concentrations
(300 tg/ml) that inhibited cell growth. Both the time-response
(Fig. 2) and dose-response (Fig. 3) curves indicate that Hb
synthesis was more sensitive than cell growth to the toxic effect
of Al. The elemental Al concentrations in Tf-Al added to media
(68 to 340 /Lg/liter) were similar to Al concentrations in the
plasma of dialysis patients with Al induced microcytic anemia
previously reported by us [12, 131.
Since both Al and Fe are taken up by FEC bound to Tf, Al
could potentially interfere with Fe uptake by FEC. To test this
hypothesis Fe and Tf uptake by Al loaded FEC was compared
with Fe and Tf uptake in control FEC at 24, 48, 72 and 96 hours
after DMSO induction. Fe and Tf uptake in Al loaded FEC were
always significantly higher compared to control FEC. Tf cell
cycling time was similar in Al loaded and control FEC, suggest-
ing that endocytosis of Tf receptor was unaltered. Therefore the
increased Fe uptake in Al loaded cells resulted from increased
Tf receptor expression. Tf uptake at 37°C measures both
surface bound and internalized Tf and therefore indicates that
total cellular Tf receptor levels are increased and not merely
redistributed. The signal for increased Tf-receptor expression in
Al loaded cells could be decreased heme or hemoglobin syn-
thesis, decreased Fe in a critical compartment or Al accumula-
tion itself. Relative rates of uptake of Fe and Al by FEC from
Tf-Fe and Tf-Al added simultaneously to media were not done
because of the lack of an Al isotope with a sufficiently long
half-life.
Mladenovic [171 has previously shown that Al and Tf and not
Al alone inhibited human erythroid colony (CFU-E) growth.
The model system described by us confirms her observation
that Al binding to Tf is necessary for its inhibitory effect on cell
growth but also differs in several aspects. FEC clearly accumu-
lated Al from Al-Tf whereas no Al uptake could be demon-
strated in CFU-E. The effect of Al on CFU-E was inhibition of
colony growth whereas in FEC hemoglobin synthesis was
affected greater than cell growth. Lastly, the FEC culture
allows us to explore the possible toxic effects of Al on the
separate processes of Fe transport, heme and globin synthesis.
The increased Fe and Tf uptake by Al loaded FEC suggests
that Al does not affect Fe uptake by FEC. Al could, however,
interfere with intracellular Fe transport after it dissociates from
Tf. Fe could accumulate in an inaccessable intracellular com-
partment viz bound to ferritin or within lysosomes as shown in
the liver [28]. Alternatively, Al could inhibit heme and/or globin
synthesis. Inhibition of erythrocyte ALA dehydrase by Al has
been shown in vivo [29] and in vitro [30]. Increased tissue
porphyrin deposits have been shown to occur in Al loaded
animals [31] and increased erythrocyte protoporphyrin levels
have been detected in dialysis patients with Al associated
anemia with reduction in protoporphyrin levels following Al
chelation [111. These studies suggest a direct toxic effect of Al
on heme synthetic enzymes. There is less evidence implicating
Al toxicity on globin synthesis. Since Al destabilizes and
cross-links with DNA at low pH [32], Al could potentially
intefere with globin transcription.
In summary, this report represents the first direct evidence
that Al gains access to the cell bound to Tf. Contrary to
speculations that Al possibly inhibits Tf and Fe uptake our
studies show that initial uptake of Tf and Fe are not involved.
Indeed, these steps are accelerated suggesting that the effect of
Al is distal to Fe uptake processes and cycling of Tf. Finally,
although in humans accumulation of Al results in a microcytic,
hypochromic anemia, no in vitro models exist prior to our
studies, including those of Mladenovic [17], in which a hy-
pochromic anemia is induced by Al. Therefore, the model
described, the DMSO induced FEC which closely mimic eryth-
roid progenator cells, allows for dissection of the mechanisms
whereby Al causes a hypochromic anemia.
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Fig. 4. Fe59 and Tf uptake in DMSO-induced
FEC grown in media containing Tf-Al (•)
compared to FEC grown in regular media C
(0). Results represent means SE of 5
experiments. *In the uptake of Tf-Al vs. C,
Fe uptake at 24 hours P < 0.03, 48 hours P <
0.02, 72 hours P < 0007, 96 hours P < 0.01
and *Tf uptake at 24 hours P < 0.004, 48
hours P < 0.02, 72 hours P < 0.0001, 96
hours P < 0.02.
Abreo et a!: Model system to study Al induced anemia 681
Acknowledgment
This study was supported by a grant from the American Heart
Association—Louisiana, Inc., and from the National Institute of Health
DK37866. We thank Shirley Perry for typing of this manuscript.
Reprint requests to Kenneth Abreo, M.D., LSU Medical Center,
1501 Kings Highway, P.O. Box 33932, Shreveport, Louisiana 71130-
3932, USA.
References
I. ALFREY AC, LEGENDRE GR, KAEHNY WD: The dialysis enceph-
alopathy syndrome. Possible aluminum intoxication. N Eng! J Med
294:184—188, 1976
2. WARD MK, FEEST TG, ELLIS HA, PARKINSON IS, KERR DNS,
HERRINOTON J, GOODE GL: Osteomalacic dialysis osteodystrophy:
Evidence for a waterbourne etiologic agent, probably aluminum.
Lancet i:841—845, 1978
3. ELLIOT HL, MACDOUGALL A!: Aluminum studies in dialysis en-
cephalopathy. Proc Eur Dial Transplant Assoc 15:157—163, 1978
4. SHORT AIK, WINNEY Ri, ROBSON JS: Reversible microcytic
hypochromic anemia in dialysis patients due to aluminum intoxica-
tion. Proc Eur Dial Transplant Assoc 17:226—233, 1980
5. PARKINSON IS, WARD MK, KERR DN: Dialysis encephalopathy,
bone disease and anemia: Aluminum-intoxication syndrome during
regular hemodialysis. J C/in Pathol (London) 34:1285, 1981
6. O'HARE JA, MIJRNAGHAN Di: Reversal of aluminum-induced
hemodialysis anemia by low-aluminum dialysate. N Engi J Med
306:654—656, 1982
7. WILLS MR, SAVORY J: Aluminum poisoning: Dialysis encephalop-
athy, osteomalacia and anemia. Lancet ii:29—34, 1983
8. CANNATA JB, RUEZ ALGERIA P, AGUSTA MV, HERRERA J, PERAL
V: Influence of aluminum hydroxide intake on hemoglobin concen-
tration and blood transfusion requirements in hemodialysis pa-
tients. Proc Eur Dial Transplant Assoc 20:719—722, 1983
9. TOUAM M, MARTINEZ F, LACOUR B, BOURDON R, ZINGRAFF J,
DIGuIuo 5, DRUEKE T: Aluminum-induced, reversible microcytic
anemia in chronic renal failure: Clinical and experimental studies.
Cl/n Nephrol 19:295—298, 1983
10. TIELMANS C, COLLART F, WENS R, SMEYERS-VERBEEKE J, VAN
HOOFF I, DRATWA M, VERBEELEN D: Improvement of anemia with
deferoxamine in hemodialysis in patients with aluminum-induced
bone disease. Cl/n Nephrol 24:237—241, 1985
11. SCHWARTZ R, DOMBROUSKI J, BURNATOWSKA-HLENDIN M,
MAYOR G: Microcytic anemia in dialysis patients: Reversible
marker of aluminum toxicity. Am J Kid Dis 9:217—223, 1987
12. ABRKO K, BROWN ST, SELLA M, TRAPP 0: Application of an
erythrocyte aluminum assay in the diagnosis of aluminum associ-
ated microcytic anemia in dialysis patients and response to defer-
oxamine therapy. J Lab C/in Med 113:50—57, 1989
13. ABREO K, BROWN ST. SELLA M: Correction of microcytosis
following elimination of an occult source of aluminum contamina-
tion of dialysate. Am J Kid Djs 13:465—468, 1989
14. SEIBERT FB, WELLS WG: The effect of aluminum on mammalian
blood and tissues. Arch Pathol 8:230—261, 1929
15. KAISER L, SCHWARZ KA, BURNATOWSKA-HLENDIN MA, MAYOR
GH: Microcytic anemia secondary to intrapentoneal aluminum in
normal and uremic rats. Kidney mt 26:269—274, 1984
16. SONNIER GB, ABREO K, BROWN ST. SELLA M: Red blood cell
aluminum and the development of microcytic anemia in rats admin-
istered aluminum. (abstract) Kidney mt 33:349, 1988
17. MLADENOVIC J: Aluminum inhibits erythropoiesis in vitro. J Clin
Invest 81:1661—1665, 1988
18. TRAPP GA: Plasma aluminum is bound to transferrin. L(fe Sci
33:311—316, 1983
19. COCHRAN T, COCHRAN M, COATES JH, KURUCSEV 1: Direct
spectrophotometric determination of the two site binding of alumi-
num to transferrin. Life Sci 40:2337—2341, 1987
20. MARTIN RB, SAVORY J, BROWN 5, BERTHOLF RL, WILLS MR:
Transfemn binding of Al3 and Fe3. C/in Chem 33:405—407, 1987
21. FRIEND C, SCHER W, HOLLAND JG, SATO T: Hemoglobin synthe-
sis in munne virus-induced leukemic cells in vitro: Stimulation of
erythroid differentiation by dimethylsulfoxide. Proc Nat'! Acad Sci
2:378—382, 1971
22. FRIEND C, SCHER W, PREISLER H: Hemoglobin biosynthesis in
murine virus-induced leukemic cells in vitro. Ann N Y Acad Sci
241:582—588, 1974
23. GLASS J, NUNEZ MT. FISHER 5, ROBINSON SH: Transfemn recep-
tors, iron transport and ferritin metabolism in Friend erythroleuke-
mia cells. Biochem Biophys Acta 542:154—162, 1978
24. ORKIN SH, HAR0SI F!, LEDER P: Differentiation in erythroleuke-
mia cells and their somatic hybrids. Proc Nat'l Acad Sci USA
72:98—102, 1975
25. TSIFTSOGLOU AS, GUSELLA JF, VOLLOCH V, HOUSMAN D: Inhi-
bition by dexamethasone of commitment to erythroid differentia-
tion in murine erythroleukemia cells. Cancer Res 39:3849—3865,
1979
26. IACOPETrA BJ, MORGAN EH: The kinetics of transferrin endocy-
tosis and iron uptake from transferrin in rabbit reticulocytes. J Biol
Chem 258:9108—9115, 1983
27. MARTIN RB: Citrate binding of Al3 and Fe3t J Inorg Biochem
28: 181—187, 1986
28. BOMMER J, WALDHERR R, WEISER P-H, RITZ E: Concommitant
lysosomal storage of iron and aluminum in dialysis patients. (letter)
Lancet i:1390, 1983
29. MEREDITH PA, ELLIOT HL, CAMPBELL BL, MooRE MR: Changes
in serum aluminum blood zinc, blood lead and erythrocyte delta-
aminolevulinic acid dehydratase activity during hemodialysis. Tox-
icol Lett 4:419—424, 1979
30. ABDULLA M, SVENSON 5, HAEGER-ARONSEN B: Antagonistic
effects of zinc and aluminum on lead inhibition of delta-aminole-
vulinic acid dehydratase. Arch Env Health 34:464—469, 1979
31. BERLYNE GM, YAGIL R: Aluminum induced porphyria in rats.
Lancet ii:1502—1503, 1973
32. KARLICK Si, EICHORN GL, CRAPPER MCLACHLAN DR: Molecular
interactions of aluminum with DNA. Neurotoxicity 1:83—88, 1980
